Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2019 | Epigenomic changes in Alzheimer’s: ANK1 DNA methylation

Katie Lunnon • 8 Apr 2019
ARUK 2019
Alzheimer’s Disease Dementia

Katie Lunnon, PhD, PGCAP, of the University of Exeter, Exeter, UK, discusses the last 5 years in epigenomics for Alzheimer’s. She highlights studies of ANK1 DNA methylation across different neurodegenerative diseases, and explains her further plans for study in this area. This interview took place at the Alzheimer’s Research UK (ARUK) Conference 2019, held in Harrogate, UK.

More from Katie Lunnon

1:30
HOXA gene cluster DNA methylation in Alzheimer's neuropathology
Katie Lunnon • 20 Mar 2021

Related Videos

3:58
Promising FONLISA test for ultrasensitive detection of plasma NfL in Alzheimer’s disease
Madison Honey • 7 Mar 2024
4:12
Updates in Alzheimer’s treatment: the potential of NSC001
Manfred Windisch • 6 Mar 2024
4:44
Influence of genetic risk for psychiatric disorders on dementia
Jenna Najar • 6 Mar 2024
2:31
Barriers to dementia treatment: awareness, accessibility, and affordability
Paola Barbarino • 23 Mar 2024
The content of VJDementia is intended for healthcare professionals